Terzapatide (Mounjaro) is a GLP-1/GIP dual agonist that combines effects of semaglutide (GLP-1 only) with additional GIP receptor activation, providing more potent glucose lowering and weight loss than GLP-1 monotherapy.
factualpending
Speaker
Dr. Kyle GilletteEvidence Quote
“there's a combined glpgip that is terzapatide serves up a tide that's munjaro”
Source
Complete Guide to Peptides for Fat Loss, Muscle Building & Longevity | Dr. Kyle Gillett MD— Thomas DeLauerCreated: 8/13/2026, 4:51:25 AM
Your notes
Loading notes...